333 related articles for article (PubMed ID: 12967694)
1. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States.
Agarwal R; Nissenson AR; Batlle D; Coyne DW; Trout JR; Warnock DG
Am J Med; 2003 Sep; 115(4):291-7. PubMed ID: 12967694
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, awareness, treatment and control of hypertension in a Canarian population. Relationship with glucose tolerance categories. The Guía Study.
de Pablos-Velasco P; Martínez-Martín FJ; Rodríguez Pérez F; Urioste LM; García Robles R
J Hypertens; 2002 Oct; 20(10):1965-71. PubMed ID: 12359974
[TBL] [Abstract][Full Text] [Related]
3. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
4. Intensive Hemodialysis, Blood Pressure, and Antihypertensive Medication Use.
Bakris GL; Burkart JM; Weinhandl ED; McCullough PA; Kraus MA
Am J Kidney Dis; 2016 Nov; 68(5S1):S15-S23. PubMed ID: 27772639
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with inadequate blood pressure control in hypertensive hemodialysis patients.
Rahman M; Dixit A; Donley V; Gupta S; Hanslik T; Lacson E; Ogundipe A; Weigel K; Smith MC
Am J Kidney Dis; 1999 Mar; 33(3):498-506. PubMed ID: 10070914
[TBL] [Abstract][Full Text] [Related]
6. [Hypertension in hemodialysis patients in Andalucia].
García Cortés MJ; Ceballos M;
Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090
[TBL] [Abstract][Full Text] [Related]
7. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999-2006.
Plantinga LC; Miller ER; Stevens LA; Saran R; Messer K; Flowers N; Geiss L; Powe NR;
Hypertension; 2009 Jul; 54(1):47-56. PubMed ID: 19470881
[TBL] [Abstract][Full Text] [Related]
9. Hypertension in pediatric long-term hemodialysis patients in the United States.
Chavers BM; Solid CA; Daniels FX; Chen SC; Collins AJ; Frankenfield DL; Herzog CA
Clin J Am Soc Nephrol; 2009 Aug; 4(8):1363-9. PubMed ID: 19556378
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive effects of long-acting calcium channel blockers on hemodialysis days--a randomized crossover trial between benidipine and nifedipine CR.
Kojima M; Taniguchi M; Sato K; Ueda R; Dohi Y
Nephron Clin Pract; 2004; 97(2):c49-53. PubMed ID: 15218330
[TBL] [Abstract][Full Text] [Related]
12. Cochrane in context: pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
[TBL] [Abstract][Full Text] [Related]
13. Treatment of hypertension in renal failure patients: when do we overtreat? When do we undertreat?
Rosansky SJ
Blood Purif; 1996; 14(4):315-20. PubMed ID: 8873957
[TBL] [Abstract][Full Text] [Related]
14. Hypertension in the hemodialysis population: a survey of 649 patients.
Salem MM
Am J Kidney Dis; 1995 Sep; 26(3):461-8. PubMed ID: 7645554
[TBL] [Abstract][Full Text] [Related]
15. Can predialysis hypertension prevent intradialytic hypotension in hemodialysis patients?
Takeda A; Toda T; Fujii T; Sasaki S; Matsui N
Nephron Clin Pract; 2006; 103(4):c137-43. PubMed ID: 16636581
[TBL] [Abstract][Full Text] [Related]
16. Frequent nurse visits decrease white coat effect in stage III hypertension.
Guerra-Riccio GM; Artigas Giorgi DM; Consolin-Colombo FM; Barreto-Filho JA; Lopes HF; Fleury Camargo AL; Moacyr Krieger E
Am J Hypertens; 2004 Jun; 17(6):523-8. PubMed ID: 15177526
[TBL] [Abstract][Full Text] [Related]
17. Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study.
London G; Schmieder R; Calvo C; Asmar R
Am J Hypertens; 2006 Jan; 19(1):113-21. PubMed ID: 16461202
[TBL] [Abstract][Full Text] [Related]
18. [Epidemiology of hypertension in the elderly population of Spain].
Banegas Banegas JR
An R Acad Nac Med (Madr); 2002; 119(1):143-52; discussion 153-9. PubMed ID: 12197202
[TBL] [Abstract][Full Text] [Related]
19. What your blood pressure isn't revealing.
Johns Hopkins Med Lett Health After 50; 2010 Nov; 22(9):4-5. PubMed ID: 21066836
[No Abstract] [Full Text] [Related]
20. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
